We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$70.4B
AUM Growth
+$3B
Cap. Flow
+$2.1B
Cap. Flow %
2.98%
Top 10 Hldgs %
18.47%
Holding
3,572
New
191
Increased
1,700
Reduced
1,394
Closed
177

Sector Composition

Rank Sector Weight
1 Technology 13.33%
2 Financials 6.37%
3 Healthcare 5.15%
4 Consumer Discretionary 4.73%
5 Industrials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNGO icon
3351
Bionano Genomics
BNGO
$13.7M
$12.5K ﹤0.01%
308
LCTX icon
3352
Lineage Cell Therapeutics
LCTX
$283M
$12.4K ﹤0.01%
+12,407
New +$13.7K
AKTS
3353
DELISTED
Akoustis Technologies Inc
AKTS
$11.7K ﹤0.01%
88,945
-16,963
-16% -$6.39K
EVA
3354
DELISTED
Enviva Inc.
EVA
$11.1K ﹤0.01%
25,812
-229
-0.9% -$115
GLDG
3355
GoldMining Inc
GLDG
$223M
$10.7K ﹤0.01%
+11,993
New +$10.6K
INVZ icon
3356
Innoviz Technologies
INVZ
$115M
$10.5K ﹤0.01%
11,306
+700
+7% +$785
KSCP icon
3357
Knightscope
KSCP
$30.2M
$9.94K ﹤0.01%
648
+100
+18% +$2K
DNMR
3358
DELISTED
Danimer Scientific, Inc.
DNMR
$9.31K ﹤0.01%
386
-55
-12% -$1.71K
LPSN icon
3359
LivePerson
LPSN
$33.6M
$8.29K ﹤0.01%
+953
New +$9.15K
GRFX
3360
DELISTED
Graphex Group
GRFX
$7.54K ﹤0.01%
+4,223
New +$6.56K
DARE icon
3361
Dare Bioscience
DARE
$21.6M
$6.72K ﹤0.01%
1,667
BMRA icon
3362
Biomerica
BMRA
$4.85M
$6.38K ﹤0.01%
1,813
AMWL icon
3363
American Well
AMWL
$221M
$6.08K ﹤0.01%
936
-3
-0.3% -$30
AKLI
3364
DELISTED
Akili Inc
AKLI
$5.41K ﹤0.01%
12,448
WWR icon
3365
Westwater Resources
WWR
$76.3M
$4.82K ﹤0.01%
+10,000
New +$4.79K
TRX icon
3366
TRX Gold Corp
TRX
$350M
$4.73K ﹤0.01%
+12,000
New +$5.32K
ASXC
3367
DELISTED
Asensus Surgical, Inc.
ASXC
$4.69K ﹤0.01%
14,072
+39
+0.3% +$11
INUV icon
3368
Inuvo
INUV
$17M
$4.62K ﹤0.01%
1,800
SGMO
3369
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4.59K ﹤0.01%
12,812
-537
-4% -$290
BETR icon
3370
Better Home & Finance Holding
BETR
$293M
$4.59K ﹤0.01%
200
BAC icon
3371
CALL
Bank of America
BAC
$448B
$3.5K ﹤0.01%
+100
New +$3.83K
PHGE icon
3372
BiomX
PHGE
$1.71M
$3.36K ﹤0.01%
+53
New +$3.57K
MTNB icon
3373
Matinas BioPharma
MTNB
$1.68M
$1.74K ﹤0.01%
+220
New +$1.99K
ABG icon
3374
Asbury Automotive
ABG
$3.73B
-1,069
Closed -$252K
ACCO icon
3375
Acco Brands
ACCO
$396M
-55,238
Closed -$310K

Similar funds

Raymond James Financial Services Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James Financial Services Advisors held 3,572 positions worth $70.4B, up 4.5% from $67.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Financial Services Advisors's Q2 2024 filing shows 191 new, 1,700 increased, 1,394 reduced and 177 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF May: 497,312 shares worth $19.1M. The largest sale was Pioneer Natural Resource Co., an estimated $44.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q2 2024 buy was FT Vest US Equity Deep Buffer ETF May: 497,312 shares worth $19.1M.
  • Raymond James Financial Services Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $114M increase.
  • Raymond James Financial Services Advisors's biggest Q2 2024 reduction was First Trust Value Line Dividend Fund, cutting an estimated $39.3M.
  • Raymond James Financial Services Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $44.4M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 18% of its $70.4B portfolio in Q2 2024.
  • Raymond James Financial Services Advisors opened 191 new positions and closed 177 in Q2 2024.
  • Raymond James Financial Services Advisors's portfolio value rose 4.5% quarter-over-quarter to $70.4B.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.